Literature DB >> 17954488

Recurrent tinea versicolor: treatment with itraconazole or fluconazole?

Anastasia Pantazidou1, Marc Tebruegge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954488      PMCID: PMC2083600          DOI: 10.1136/adc.2007.124958

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  8 in total

1.  Fluconazole vs. itraconazole in the treatment of tinea versicolor.

Authors:  F Montero-Gei; M E Robles; P Suchil
Journal:  Int J Dermatol       Date:  1999-08       Impact factor: 2.736

2.  Fluconazole versus itraconazole in the treatment of tinea versicolor.

Authors:  O Köse
Journal:  Int J Dermatol       Date:  1995-07       Impact factor: 2.736

3.  The epidemiology of pityriasis versicolor in Malawi, Africa.

Authors:  J M Pönnighaus; P E Fine; J Saul
Journal:  Mycoses       Date:  1996 Nov-Dec       Impact factor: 4.377

4.  The incidence of tinea versicolor in central Sweden.

Authors:  L Hellgren; J Vincent
Journal:  J Med Microbiol       Date:  1983-11       Impact factor: 2.472

5.  Comparative efficacy of ketoconazole and fluconazole in the treatment of pityriasis versicolor: a one year follow-up study.

Authors:  C S Bhogal; A Singal; M C Baruah
Journal:  J Dermatol       Date:  2001-10       Impact factor: 4.005

6.  Safety and tolerability of fluconazole in children.

Authors:  V Novelli; H Holzel
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

7.  Single-dose fluconazole versus itraconazole in pityriasis versicolor.

Authors:  R Partap; I Kaur; A Chakrabarti; B Kumar
Journal:  Dermatology       Date:  2004       Impact factor: 5.366

Review 8.  Efficacy and safety of itraconazole use in children.

Authors:  Aditya K Gupta; Elizabeth A Cooper; Gabriele Ginter
Journal:  Dermatol Clin       Date:  2003-07       Impact factor: 3.478

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.